Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1987 Apr;25(4):744–745. doi: 10.1128/jcm.25.4.744-745.1987

Pseudomonas sp. group Ve-2 bacterial peritonitis in a patient on continuous ambulatory peritoneal dialysis.

I J Amber, L G Reimer
PMCID: PMC266075  PMID: 3571484

Abstract

Pseudomonas sp. group Ve-2 peritonitis occurred in a patient on continuous ambulatory peritoneal dialysis who had recently completed intraperitoneal cephalosporin therapy for culture-negative peritonitis. This is the second reported case of peritonitis in this population of patients due to this unusual organism, which is usually resistant to most cephalosporin antibiotics.

Full text

PDF
744

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
  2. Fass R. J., Barnishan J. In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents. Rev Infect Dis. 1980 Nov-Dec;2(6):841–853. doi: 10.1093/clinids/2.6.841. [DOI] [PubMed] [Google Scholar]
  3. Gilardi G. L., Hirschl S., Mandel M. Characteristics of yellow-pigmented nonfermentative bacilli (groups VE-1 and VE-2) encountered in clinical bacteriology. J Clin Microbiol. 1975 Apr;1(4):384–389. doi: 10.1128/jcm.1.4.384-389.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Nolph K. D., Cutler S. J., Steinberg S. M., Novak J. W. Findings from the NIH National CAPD registry. January 1985. Trans Am Soc Artif Intern Organs. 1985;31:333–337. [PubMed] [Google Scholar]
  5. Pedersen M. M., Marso E., Pickett M. J. Nonfermentative bacilli associated with man. 3. Pathogenicity and antibiotic susceptibility. Am J Clin Pathol. 1970 Aug;54(2):178–192. doi: 10.1093/ajcp/54.2.178. [DOI] [PubMed] [Google Scholar]
  6. Pickett M. J., Pedersen M. M. Characterization of saccharolytic nonfermentative bacteria associated with man. Can J Microbiol. 1970 May;16(5):351–362. doi: 10.1139/m70-062. [DOI] [PubMed] [Google Scholar]
  7. Pien F. D., Chung E. Y. Group Ve infection: case report of group Ve-2 septicemia and literature review. Diagn Microbiol Infect Dis. 1986 Jul;5(2):177–180. doi: 10.1016/0732-8893(86)90120-3. [DOI] [PubMed] [Google Scholar]
  8. Pien F. D. Group VE-2 (Chromobacterium typhiflavum) bacteremia. J Clin Microbiol. 1977 Oct;6(4):435–436. doi: 10.1128/jcm.6.4.435-436.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Rubin J., Rogers W. A., Taylor H. M., Everett E. D., Prowant B. F., Fruto L. V., Nolph K. D. Peritonitis during continuous ambulatory peritoneal dialysis. Ann Intern Med. 1980 Jan;92(1):7–13. doi: 10.7326/0003-4819-92-1-7. [DOI] [PubMed] [Google Scholar]
  10. Silver M. R., Felegie T. P., Sorkin M. I. Unusual bacterium, group Ve-2, causing peritonitis in a patient on continuous ambulatory peritoneal dialysis. J Clin Microbiol. 1985 May;21(5):838–839. doi: 10.1128/jcm.21.5.838-839.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Strandberg D. A., Jorgensen J. H., Drutz D. J. Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli. Antimicrob Agents Chemother. 1983 Aug;24(2):282–286. doi: 10.1128/aac.24.2.282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Stratton C. W., Reller L. B. Serum dilution test for bactericidal activity. I. Selection of a physiologic diluent. J Infect Dis. 1977 Aug;136(2):187–195. doi: 10.1093/infdis/136.2.187. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES